glp 1 during pregnancy Use of GLP-1 drugs early in should not cause alarm, analysis suggests GLP-1 receptor agonists, semaglutide, liraglutide,

This matters because dosage adjustments are common with GLP-1 medications, especially in the first few months

Pharmacological guidance recommends discontinuing therapy after at least 5 half-lives to minimize fetal exposure

For medications treating chronic conditions like obesity, long-term safety data accumulates after approval through post-market surveillance

pharmacies." As of June 2026, the specific pharmacy partners are not named in Omzo's consumer-facing materials, which means buyers cannot independently verify whether those pharmacies operate under 503A or 503B frameworks

Daily Nutrient Intake*

Andreadis P, Karagiannis T, Malandris K, Avgerinos I, Liakos A, Manolopoulos A, et al